An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know
The disposition comes as HIMS stock has declined 38% over the past 12 months.
Overview
Chief Financial Officer Oluyemi Okupe reported the disposal of 101,000 shares of Hims & Hers Health, Inc. (NYSE:HIMS) across transactions occurring between June 18 and August 14, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($31.92); post-transaction value based on the August 17 market close ($28.61).
Details
Hims & Hers Health is a leading digital health platform with a market capitalization of $6.4 billion and TTM revenue of $2.6 billion, positioning it as a significant player in the telehealth and direct-to-consumer healthcare space. The company's integrated platform model--combining virtual medical consultations with direct product fulfillment--creates operational leverage and customer stickiness across its growing user base. Despite current net losses, the company's substantial revenue scale and expanding digital health market opportunity underscore its strategic positioning within the evolving healthcare delivery landscape.
Source
Originally published at www.fool.com.